• Latest Posts
Opinion 18 Jan 2023

Innovation in life sciences requires collaboration and community

Ascletis phase I COVID trial progressing

Breast cancer most studied disease area in 2022

ExeVir Bio secures funding for COVID program

Ethris and DIOSynVax to develop mRNA betacoronavirus vaccine

Watch: Atriva Therapeutics at BIO-Europe

ADVERTISEMENT

Nykode Therapeutics and Richter-Helm BioLogics announce partnership

Tachmed aiming to make healthcare more accessible

Startup USSF bringing oral COVID vaccine to market

Ascletis announces positive COVID-19 trial results

MetrioPharm reveals COVID-19 study data

ExPLoRNA Therapeutics receives mRNA technology funding

ADVERTISEMENT